Seraseq next-generation sequencing (NGS) reference materials enable the promise of clinical genomics by helping scientists and clinicians build, validate, implement, and standardize better clinical genomics assays. Using highly innovative and patented technology, SeraCare designs and manufactures highly multiplexed, patient-like reference materials for NGS assays used by clinical and translational research laboratories that conduct molecular testing of patient samples for:
Seraseq reference materials are formatted as purified DNA (gDNA), purified circulating tumor DNA (ctDNA), synthetic plasma-like material, as well as formalin-fixed, paraffin-embedded (FFPE) material. These formats serve as full-process reference materials for end-to-end monitoring of NGS workflows:
These highly multiplexed reference materials are manufactured in cGMP-compliant, ISO 13485-certified facilities and provide a consistent and reliable positive and negative control material for NGS assay development, validation, clinical deployment, lot-to-lot testing, in-kit controls, and daily run control QC.
The SeraCare reference materials are the only references that let you select the specific allelic frequency (AF), or a mixed set of AF’s to cover the total range of your assay. By specifying AF% in the reference materials it is now possible to confirm the sensitivity of your complete workflow. Never doubt your assay or your sensitivity anymore. Confirm the diagnosis with absolute certainty and decisions for specific drug treatment will become more accurate then ever.
Because of the unique production technique, SeraCare can easily create custom panels for your specific project. Don’t hesitate to ask us about the possibilities.
Together with prominent research specialists and clinical genomics experts, SeraCare develops and improves their reference materials. If you are interested in a collaboration for a new application let us know.
↓ Seraseq™ ctDNA Mutation Mix V2 product sheet
↓ Seraseq™ ctDNA Reference Material V2 product sheet
↓ Seraseq™ ctDNA Complete™ Mutation Mix product sheet
↓ Seraseq™ ctDNA Complete™ Reference Material product sheet
↓ Seraseq™ ctDNA MRD Panel Mix product sheet
↓ Seraseq® ctDNA Tumor Mutational Burden (TMB) Reference Material product sheet
↓ Seraseq™ Tumor Mutation DNA Mix AF7/AF10 v2 product sheet
↓ Seraseq™ Tri-Level Tumor Mutation DNA Mix v2 product sheet
↓ Seraseq™ FFPE WT (DNA/RNA) Reference Material product sheet
↓ Seraseq® Compromised FFPE Tumor DNA Reference Material product sheet
↓ Seraseq® Compromised FFPE WT (DNA/RNA) Reference Material product sheet
↓ Seraseq® TNA (DNA/RNA) WT Mix product sheet
↓ Seraseq™ Breast CNV Mix 3/6/12 copies product sheet
↓ Seraseq™ Lung & Brain CNV Mix 3/6/12 copies product sheet
↓ Seraseq™ FFPE Tumor Fusion RNA Reference Material v4 product sheet
↓ Seraseq™ Fusion RNA Mix v4 product sheet
↓ Seraseq® FFPE NTRK Fusion RNA Reference Material product sheet
↓ Seraseq® FFPE NTRK Fusion RNA Mix product sheet
↓ Seraseq® FFPE, gDNA & Blood Tumor Mutational Burden (TMB) product sheet
↓ Seraseq™ Myeloid Mutation DNA / RNA Mix product sheet
↓ Seraseq® MSI Reference Panel Mix product sheet
ctDNA Mix V2 | ||
0710-0139 | Oncology | Seraseq™ ctDNA Mutation Mix v2 AF2% |
0710-0140 | Oncology | Seraseq™ ctDNA Mutation Mix v2 AF1% |
0710-0141 | Oncology | Seraseq™ ctDNA Mutation Mix v2 AF0.5% |
0710-0142 | Oncology | Seraseq™ ctDNA Mutation Mix v2 AF0.25% |
0710-0143 | Oncology | Seraseq™ ctDNA Mutation Mix v2 AF0.125% |
0710-0144 | Oncology | Seraseq™ ctDNA Mutation Mix v2 WT |
0710-0203 | Oncology | Seraseq™ ctDNA Reference Material v2 AF2% |
0710-0204 | Oncology | Seraseq™ ctDNA Reference Material v2 AF1% |
0710-0205 | Oncology | Seraseq™ ctDNA Reference Material v2 AF0.5% |
0710-0206 | Oncology | Seraseq™ ctDNA Reference Material v2 AF0.25% |
0710-0207 | Oncology | Seraseq™ ctDNA Reference Material v2 AF0.125% |
0710-0208 | Oncology | Seraseq™ ctDNA Reference Material v2 WT |
ctDNA Complete Mix | ||
0710-0528 | Oncology | Seraseq™ ctDNA Complete™ Mutation Mix AF5% |
0710-0529 | Oncology | Seraseq™ ctDNA Complete™ Mutation Mix AF2.5% |
0710-0530 | Oncology | Seraseq™ ctDNA Complete™ Mutation Mix AF1% |
0710-0531 | Oncology | Seraseq™ ctDNA Complete™ Mutation Mix AF0.5% |
0710-0532 | Oncology | Seraseq™ ctDNA Complete™ Mutation Mix AF0.1% |
0710-0533 | Oncology | Seraseq™ ctDNA Complete™ Mutation Mix WT |
0710-0669 | Oncology | Seraseq™ ctDNA Complete™ Reference Material AF5% |
0710-0670 | Oncology | Seraseq™ ctDNA Complete™ Reference Material AF2.5% |
0710-0671 | Oncology | Seraseq™ ctDNA Complete™ Reference Material AF1% |
0710-0672 | Oncology | Seraseq™ ctDNA Complete™ Reference Material AF0.5% |
0710-0673 | Oncology | Seraseq™ ctDNA Complete™ Reference Material AF0.1% |
0710-0674 | Oncology | Seraseq™ ctDNA Complete™ Reference Material WT |
MRD Monitoring | ||
0710-2146 | Oncology | Seraseq ctDNA MRD Panel Mix (NEW) |
ctDNA TMB Reference Materials | ||
0710-2087 | Oncology | Seraseq Blood TMB Mix Score 7 (NEW) |
0710-2090 | Oncology | Seraseq Blood TMB Mix Score 26 (NEW) |
Tumor Mutation/WT | ||
0710-0094 | Oncology | Seraseq™ Tumor Mutation DNA Mix v2 AF10 HC |
0710-0095 | Oncology | Seraseq™ Tumor Mutation DNA Mix v2 AF7 HC |
0710-0097 | Oncology | Seraseq™ Tri-Level Tumor Mutation DNA Mix v2 HC |
0710-0137 | Oncology | Seraseq™ FFPE WT (DNA/RNA) Reference Material |
0710-1492 | Oncology | Seraseq® Compromised FFPE Tumor DNA Reference Material (NEW) |
0710-1710 | Oncology | Seraseq® Compromised FFPE WT (DNA/RNA) Reference Material (NEW) |
0710-1580 | Oncology | Seraseq® TNA (DNA/RNA) WT Mix (NEW) |
0710-2129 | Oncology | Seraseq Whole Transcriptome RNA Seq Mix (NEW) |
Myeloid | ||
0710-0408 | Oncology | Seraseq™ Myeloid Mutation DNA Mix |
0710-0407 | Oncology | Seraseq™ Myeloid Fusion RNA Mix |
Breast/Lung/Brain | ||
0710-0411 | Oncology | Seraseq™ Breast CNV Mix, +3 copies |
0710-0412 | Oncology | Seraseq™ Breast CNV Mix, +6 copies |
0710-0413 | Oncology | Seraseq™ Breast CNV Mix, +12 copies |
0710-0414 | Oncology | Seraseq™ Lung & Brain CNV Mix, +3 copies |
0710-0415 | Oncology | Seraseq™ Lung & Brain CNV Mix, +6 copies |
0710-0416 | Oncology | Seraseq™ Lung & Brain CNV Mix, +12 copies |
Fusion/NTRK | ||
0710-0496 | Oncology | Seraseq™ FFPE Tumor Fusion RNA Reference Material v4 |
0710-0497 | Oncology | Seraseq™ Fusion RNA Mix v4 |
0710-1031 | Oncology | Seraseq® FFPE NTRK Fusion RNA Reference Material |
0710-1696 | Oncology | Seraseq® FFPE NTRK Fusion RNA Mix (NEW) |
Tumor Mutational Burden | ||
0710-1307 | Oncology | Seraseq® FFPE TMB Reference Material Score 26 |
0710-1308 | Oncology | Seraseq® FFPE TMB Reference Material Score 9 |
0710-1309 | Oncology | Seraseq® FFPE TMB Reference Material Score 20 |
0710-1310 | Oncology | Seraseq® FFPE TMB Reference Material Score 7 |
0710-1618 | Oncology | Seraseq® FFPE TMB Reference Material Score 13 |
0710-1323 | Oncology | Seraseq® Genomic DNA TMB Mix Score 26 |
0710-1324 | Oncology | Seraseq® Genomic DNA TMB Mix Score 20 |
0710-1586 | Oncology | Seraseq® Genomic DNA TMB Mix Score 13 |
0710-1325 | Oncology | Seraseq® Genomic DNA TMB Mix Score 9 |
0710-1326 | Oncology | Seraseq® Genomic DNA TMB Mix Score 7 |
Microsattelite instability | ||
0710-1670 | Oncology | Seraseq® gDNA MSI-High Mix (NEW) |
0710-1675 | Oncology | Seraseq® MSI Reference Panel Mix AF5% (NEW) |
0710-1676 | Oncology | Seraseq® MSI Reference Panel Mix AF20% (NEW) |
0720-0019 | NIPT | Seraseq™ T21 Aneuploidy Reference Material (12% target fetal fraction) |
0720-0018 | NIPT | Seraseq™ T18 Aneuploidy Reference Material (12% target fetal fraction) |
0720-0017 | NIPT | Seraseq™ T13 Aneuploidy Reference Material (12% target fetal fraction) |
0720-0020 | NIPT | Seraseq™ Aneuploidy Negative (Euploid) Reference Material |
0720-0167 | NIPT | Seraseq® Trisomy 21 Male Matched Reference Material |
0720-0168 | NIPT | Seraseq® Trisomy 21 Female Matched Reference Material |
0720-0169 | NIPT | Seraseq® Euploid Male Matched Reference Material |
0720-0170 | NIPT | Seraseq® Euploid Female Matched Reference Material |
0720-0171 | NIPT | Seraseq® Trisomy 18 Male Matched Reference Material (NEW) |
0720-0172 | NIPT | Seraseq® Trisomy 18 Female Matched Reference Material |
0720-0779 | NIPT | Seraseq® Trisomy 13 Male Matched Reference Material (NEW) |
0720-0173 | NIPT | Seraseq® 22q11 Male Matched Reference Material |
0720-0775 | PGT | Seraseq® PGT-A Trisomy 21 Reference Material (NEW) |
0720-0776 | PGT | Seraseq® PGT-A Trisomy 18 Reference Material (NEW) |
0720-0777 | PGT | Seraseq® PGT-A Trisomy 13 Reference Material (NEW) |
0720-0778 | PGT | Seraseq® PGT-A Euploid Reference Material (NEW) |
0740-0025 | Seraseq™ HIV-1 DR & Tropism RF v2 (MF40) |
0740-0026 | Seraseq™ HIV-1 DR & Tropism RF v2(MF1-20) |
0740-0001 | Seraseq™ HIV-1 BK132-B Ref Material |
0740-0002 | Seraseq™ HIV-1 93/US/144-B Ref Material |
0740-0003 | Seraseq™ HIV-1 CM237-B Ref Material |
0740-0004 | Seraseq™ HIV-1 US1-B Ref Material |
0740-0005 | Seraseq™ HIV-1 93/US/143-B Ref Material |
0740-0006 | Seraseq™ HIV-1 93/US/141-B Ref Material |
0740-0007 | Seraseq™ HIV-1 I-2496-CRF02_AG Ref Mat |
0740-0008 | Seraseq™ HIV-1 CM235-CRF01_AE Ref Mat |
0740-0009 | Seraseq™ HIV-1 7388-B Ref Material |
0740-0010 | Seraseq™ HIV-1 7384-B Ref Material |
0740-0011 | Seraseq™ HIV-1 2529-B Ref Material |
0740-0012 | Seraseq™ HIV-1 2808-B Ref Material |
0740-0021 | Cardio | Seraseq™ Cardiomyopathy Reference Material |
0730-0003 | Inherited | Seraseq™ Inherited Cancer DNA Mix v1 |